Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry-Reference-Cited by-同舟云学术

Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry

Published:2023-07 Issue:3 Volume:139 Page:107611
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Lessard Lola E.R.,Tard Céline,Salort-Campana Emmanuelle,Sacconi Sabrina,Béhin Anthony,Bassez Guillaume,Orlikowski David,Merle Philippe,Nollet Sylvain,Gallay Laure,Bérard Frédéric,Robinson Philip,Bouhour Françoise,Laforêt Pascal

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference39 articles.

1. Pompe’s disease;Van der Ploeg;Lancet,2008

2. Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis;Schoser;J. Neurol.,2017

3. European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience;Van der Ploeg;Eur. J. Neurol.,2017

4. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network;Solé;Rev. Neurol. (Paris),2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy;Molecular Diagnosis & Therapy;2024-08-12

2. Reply to Aranda et al.;Pediatric Allergy and Immunology;2024-08

3. Evaluating avalglucosidase alfa for the management of late-onset Pompe disease;Expert Review of Neurotherapeutics;2024-01-23